FAKTOR-OPTIONSSCHEIN - ELI LILLY & CO | Market Closed - Boerse Frankfurt Warrants 03:42:37 2024-05-27 pm EDT | ||
| 533.2 EUR | +0.57% |
|
| Current month | +8.81% | ||
| 1 month | +35.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-05-27 | 535.3 | +0.95% |
| 24-05-24 | 530.2 | +0.37% |
| 24-05-23 | 528.3 | +3.21% |
| 24-05-22 | 511.8 | -1.47% |
| 24-05-21 | 519.5 | +11.07% |
Real-time Boerse Frankfurt Warrants
Last update May 27, 2024 at 03:42 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SD42D5 |
| ISIN | DE000SD42D51 |
| Date issued | 2021-03-29 |
| Strike | 183.1 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 590.2 € |
|---|---|
| Lowest since issue | 7 € |
| Spread | 6.69 € |
| Spread % | 1.23% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
807.4
USD
Average target price
850.8
USD
Spread / Average Target
+5.37%
- Stock Market
- Certificates
- Certificat
